Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1β activity but not binding: Regulation of IL-1 responses is via type I receptor, not the accessory protein

Journal of Immunology

Volumn 160, Issue 7, 1998, Pages 3170-3179

  Yoon, Do Young ^a,b   Dinarello, Charles A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; CELL DIVISION; CELL LINE; HUMANS; IMMUNE SERA; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1; INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECEPTORS, INTERLEUKIN-1;

EID: 0032055841     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Dinarello, C. A. 1996. Biological basis for interleukin-1 in disease. Blood 87: 2095.
2. O'Neill, L. A. J. 1995. Towards an understanding of the signal transduction pathways for interleukin-1. Biochim. Biophys. Acta 1266:31.
3. Bird, T. A., P. R. Sleath, P. C. de Roos, S. K. Dower, and G. D. Virca. 1991. Interleukin-1 represents a new modality for the activation of extracellular signal-related kinases/microtubule-associated protein-2 kinases. J. Biol. Chem. 266:22661.
4. Uciechowski, P., J. Saklatvala, J. von der Ohe, K. Reshe, M. Szamel, and M. Kracht. 1996. Interleukin-1 activates jun N-terminal kinases JNK1 and JNK2 but not extracellular regulated MAP kinase (ERK) in human glomerular mesangial cells. FEBS Lett. 394:273.
5. Martin, M. U., and W. Falk. 1997. The interleukin-1 receptor complex and interleukin-1 signal transduction. Eur. Cytokine Netw. 8:5.
6. Dower, S. K., J. M. Wignall, K. Schooley, C. J. McMahan, J. L. Jackson, K. S. Prickett, S. Lupton, D. Cosman, and J. E. Sims. 1989. Retention of ligand binding activity by the extracellular domain of the IL-1 receptor. J. Immunol. 142:4314.
7. Dower, S. K., C. McMahan, J. Flack, C. Grubin, S. Lupton, B. Moseley, and G. E. Sims. 1990. Molecular characterization of two types of interleukin-1 receptor coding peptides on murine and human cells. J. Leukocyte Biol. 1(Suppl.): 103.
8. Sims, J. E., M. A. Gayle, J. L. Slack, M. R. Alderson, T. A. Bird, J. G. Giri, F. Colotta, F. Re, A. Mantovani, K. Shanebeck, K. H. Grabstein, and S. K. Dower. 1993. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90:6155.
9. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. Giri, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472.
10. Colotta, F., S. Saccani, J. G. Giri, S. K. Dower, J. E. Sims, M. Introna, and A. Mantovani. 1996. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156:2534.
11. Bergers, G., A. Reikerstorfer, S. Braselmann, P. Graninger, and M. Busslinger. 1994. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13:1176.
12. Yanagisawa, K., T. Takagi, T. Tsukamoto, T. Tetsuka, and S. Tominaga. 1993. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin-1 receptor type I. FEBS Lett. 318:83.
13. Gayle, M. A., J. L. Slack, T. P. Bonnert, B. R. Renshaw, G. Sonoda, T. Taguchi, J. R. Testa, S. K. Dower, and J. E. Sims. 1996. Cloning of a putative ligand for the T1/ST2 receptor. J. Biol. Chem. 271:5784.
14. Mitcham, J. L., P. Parnet, T. P. Bonnert, K. E. Garka, M. J. Gerhart, J. L. Slack, M. A. Gayle, S. K. Dower, and J. E. Sims. 1996. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J. Biol. Chem. 271: 5777.
15. Heldin, C. H., and A. Ostman. 1996. Ligand-induced dimerization of growth factor receptors: variations on the theme. Cytokine Growth Factor Rev. 7:3.
16. Savage, N., A. J. Puren, S. F. Orencole, T. Ikejima, B. D. Clark, and C. A. Dinarello. 1989. Studies on IL-1 receptors on D10S T-helper cells: demonstration of two molecularly and antigenically distinct IL-1 binding proteins. Cytokine 1:23.
17. Chizzonite R., T. Truitt, P. L. Kilian, A. S. Stern, P. Nunes, K. P. Parker, K. L. Kaffka, A. O. Chua, D. K. Lugg, and U. Gubler. 1989. Two high-affinity interleukin 1 receptors represent separate gene products. Proc. Natl. Acad. Sci. USA 86:8029.
18. Greenfeder, S. A., P. Nunes, L. Kwee, M. Labow, R. A. Chizzonite, and G. Ju. 1995. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270:13757.
19. Parnet, P., K. E. Garka, T. P. Bonnert, S. K. Dower, and J. E. Sims. 1996. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 271:3967.
20. Wesche, H., D. Neumann, K. Resch, and U. M. Martin. 1996. Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness. FEBS Lett. 391:104.
21. Korherr, C., R. Hofmeister, H. Wesche, and W. Falk. 1997. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27:262.
22. Orencole, S. F., and C. A. Dinarello. 1989. Characterization of a subclone (D10S) of the D10. G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in the absence of mitogens. Cytokine 1:14.
23. Chou, P. Y., and G. D. Fasman. 1974. Prediction of protein conformation. Biochemistry 13:222.
24. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105.
25. Albericio, F., N. Kneib-Cordonier, S. Biancalana, L. Gera, R. I. Masada, D. Hudson, and G. Barany. 1990. Preparation and application of the PAL handle for the solid phase synthesis of C-terminal peptide amides under mild conditions. J. Org. Chem. 55:3733.
26. Walter, G., K. H. Scheidtmann, A. Carbone, A. P. Laudano, and R. F. Doolittle. 1980. Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc. Natl. Acad. Sci. USA 77:5197.
27. Reichlin, M. 1980. Use of glutaraldehyde as a coupling agent for proteins and peptides. In Methods in Enzymology, Vol. 70. H. V. Vunakis and J. J. Langone, eds. Academic Press, New York, p. 159.
28. Bauminger, S., and M. Wilchek. 1980. The use of carbodiimides in the preparation of immunizing conjugates. In Methods in Enzymology, Vol. 70. H. V. Vunakis and J. J. Langone, eds. Academic Press, New York, p. 151.
29. Carter, J. M. 1994. Techniques for conjugation of synthetic peptides to carrier molecules. In Peptide Analysis Protocols in Methods in Molecular Biology, Vol. 36. B. M. Dunn and M. W. Pennington, eds. Humana Press, Totowa, p. 155.
30. Yamada, H., T. Imoto, K. Fujita, K. Okazaki, and M. Motomura. 1981. Selective modification of aspartic acid-101 in lysozyme by carbodiimide reaction. Biochemistry 20:4836.
31. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 227:680.
32. Hijmans, W., H. R. E. Schuit, and F. Klein. 1969. An immunofluorescence procedure for the detection of intracellular immunoglobulins. Clin. Exp. Immunol. 4:457.
33. Ye, K., K.-C. Koch, B. D. Clark, and C. A. Dinarello. 1992. Interleukin-1 down-regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression. Immunology 75:427.
34. Labriola-Tompkins, E., C. Chandran, K. L. Kaffka, B. J. Biondi, B. J. Graves, M. Hatada, V. S. Madison, J. Karas, P. L. Kilian, and G. Ju. 1991. Identification of the discontinuous binding site in human interleukin-1β for the type I interleukin-1 receptor. Proc. Natl. Acad. Sci. USA 88:11182.
35. Evans, R. J., J. Bray, J. D. Childs, G. P. A. Vigers, B. J. Brandhuber, J. J. Skalicky, R. C. Thompson, and S. P. Eisenberg. 1994. Mapping receptor binding sites in the IL-1 receptor antagonist and IL-1β by site-directed mutagenesis: identification of a single site in IL-1ra and two sites in IL-1β. J. Biol. Chem. 270:11477.
36. Vigers, G. P. A., L. J. Anderson, P. Caffes, and B. J. Brandhuber. 1997. Crystal structure of the type-1 interleukin-1 receptor complexed with interleukin-1β. Nature 386:190.
37. Schreuder, H., C. Tardif, S. Trump-Kallmeyer, A. Soffientini, E. Sarubbi, A. Akeson, T. Bowlin, S. Yanofsky, and R. W. Barrett. 1997. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386:194.
38. Ju, G., E. Labriola-Tompkins, C. A. Campen, W. R. Benjamin, J. Karas, J. Plocinski, D. Biondi, K. Kaffka, P. Kilian, S. P. Eisenberg, and R. J. Evans. 1991. Conversion of the IL-1 receptor antagonist into an agonist by a single amino acid substitution. Proc. Natl. Acad. Sci. USA 88:2658.
39. Taga, T., M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa, T. Matsuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573.
40. Pantoliano, M. W., R. A. Horlick, B. A. Springer, D. E. VanDyk, T. Tobery, D. R. Wetmore, J. D. Lear, A. T. Nahapetian, J. D. Bradley, and W. P. Sisk. 1994. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 33:10229.
41. Blechman, J. M., S. Lev, J. Barg, M. Eisenstein, B. Vaks, Z. Vogel, D. Givol, and Y. Yarden. 1995. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80:103.
42. Hercus, T. R., C. J. Bagley, B. Cambareri, M. Dottore, J. M. Woodcock, M. A. Vadas, M. F. Shannon, and A. F. Lopez. 1994. Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc. Natl. Acad. Sci. USA 91:5838.
43. Cassatella, M. A., L. Meda, S. Gasperini, F. Calzetti, and S. Bonora. 1994. Interleukin 10 (IL-10) up-regulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 179:1695.
44. Chizzolini, C., R. Chicheportiche, D. Burger, and J-M. Dayer. 1997. Human Th1 cells preferentially induce interleukin-1β while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes. Eur. J. Immunol. 27:171.